Home › Trial NCT04351204
The MR-Linac Technical Feasibility Protocol
- Trial IDNCT04351204
- StatusUnknown
- PhaseN/A
- Study typeInterventional
- SponsorThe Netherlands Cancer Institute
- Enrollment140
- Start date2019-01-22
- ConditionsTumors at All Sites Which Will Receive Radiotherapy
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.